Abstract
Prostaglandin endoperoxide H synthases-1 and -2 (PGHS-1 and -2) catalyze the committed step in the formation of prostanoids (prostaglandins, thromboxane A2 (l-6). PGHSs catalyze two separate reactions: a cyclooxygenase reaction in which arachidonate is converted to prostaglandin G2 (PGG2) and a peroxidase reaction in which PGG2undergoes a two-electron reduction to PGH2. The cyclooxygenase reaction begins with a rate-limiting abstraction of the 13-proS hydrogen from arachidonate to yield an arachidonyl radical (7,8). This is followed by sequential oxygen additions at C-11 and C-15 to yield the prostaglandin endoperoxide PGG2. PGHSs exhibit some lipoxygenase activity producing small amounts of 11-hydroperoxy-5Z,8Z,12E,14Z-eicosatetraenoic acid (11-HPETE) and 15-hydroperoxy-5Z,8Z,11Z,13E-eicosatetraenoic acid (15-HPETE) from arachidonic acid (9, 10). Aspirin-acetylated PGHS-2, which has no cyclooxygenase activity, synthesizes 15R-HPETE (10,11). Studies comparing native and aspirinacetylated PGHS-2 have raised the possibility that arachidonate can bind in distinct orientations in the PGHS-2 active site to produce either PGG2, 1 l R-HPETE or 15RHPETE (10). Here we develop the concept that arachidonate can be bound in the cyclooxygenase active site of ovine (o)PGHS-1 in at least three different, catalytically competent arrangements that lead to PGG2, 11R-HPETE, and 15R/S-HPETE, respectively, and that these three arrangements of arachidonate occur subsequent to its entry into the cyclooxygenase active site.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Smith, W. L., Marnett, L. J., and DeWitt, D. L. (1991) Pharmacol. Ther.49 153–179
Smith, W. L., and DeWitt, D. L. (1996) in Advances in Immunology, Vol. 62 (Dixon, F. J., ed), pp. 167–215, Academic Press, San Diego, CA
Smith, W. L., Garavito, R. M., and DeWitt, D. L. (1996)J. Biol. Chem.271 33157–33160
Marnett, L. J., Rowlinson, S. W., Goodwin, D. C., Kalgutkar, A. S., and Lanzo, C. A. (1999) J. Biol. Chem.274 22903–22906
DeWitt, D. L. (1999)Mol. Pharmacol.55 625–631
Smith, W. L., Garavito, R. M., and DeWitt, D. L. (2000) Ann. Rev. Biochem.in press.
Hamberg, M., and Samuelsson, B. (1967)J. Biol. Chem. 242 5336–5343
Tsai, A., Kulmacz, R. J., and Palmer, G. (1995)J. Biol. Chem.270 10503–10508
Hecker, M., Ullrich, V., Fischer, C., and Meese, C.O. (1987)Eur. J. Biochem.169 113–123
Xiao, G., Tsai, A. L., Palmer, G., Boyar, W. C., Marshall, P. J., and Kulmacz, R. J. (1997) Biochemistry 36 1836–1845
Lecomte, M., Laneuville, O., Ji, C., DeWitt, D. L., and Smith, W. L. (1994)J. Biol. Chem.269 13207–13215
Gierse, J. K., Hauser, S. D., Creely, D. P., Koboldt, C., Rangwala, S. H., Isakson, P. C., and Seibert, K. (1995) Biochem. J.305 479–484
Barnett, J., Chow, J., Ives, D., Chiou, M., Mackenzie, R., Osen, E., Nguyen, B., Tsing, S., Bach, C., Freire, J., et al. (1994)Biochim. Biophys. Acta 1209, 130–139
Meade, E. A., Smith, W. L., and DeWitt, D. L. (1993) J. Biol. Chem.268 6610–6614
Laneuville, O. I., Breuer, D. K., Xu, N., Huang, Z. H., Gage, D. A., Watson, J. T., Lagarde, M., DeWitt, D. L., and Smith, W. L. (1995) J. Biol. Chem. 270 19330–19336
Shimokawa, T., and Smith, W. L. (1992)J. Biol.Chem. 267 12387–12392
Laneuville, O., Breuer, D. K., Dewitt, D. L., Hla, T., Funk, C. D., and Smith, W. L. (1994) J. Pharmacol. Exp. Ther. 271 927–934
Oliw, E. H., Hornsten, L., Sprecher, H., and Hamberg, M. (1993)Arch. Biochem. Biophys.305288–297
Schneider, C., and Brash, A.R. (1999) J. Biol. Chem. 275 4743–4746
Porter, N.A., Wolf, R.A., Pagels, W.R., and Marnett, L.J. (1980) Biochem. Biophys. Res. Commun. 92 349–355
Hamberg, M., Su, C., and Oliw, E. (1998) J. Biol. Chem. 273 13080–13088
Picot, D., Loll, P.J., and Garavito, M. (1994)Nature 367 243–249
DeWitt, D. L., El-Harith, E. A., Kraemer, S. A., Andrews, M. J., Yao, E. F., Armstrong, R.L. and Smith, W. L. (1990) J. Biol. Chem. 265 5192–5198
Loll, P. J., Picot, D., and Garavito, R. M. (1995) Nature Str. Biol. 2 637–643.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Thuresson, E.D., Lakkides, K.M., Smith, W.L. (2002). Pgg211r-Hpete and 15r/S-Hpete are Formed From Different Conformers of Arachidonic Acid in the Prostaglandin Endoperoxide H Synthase-1 Cyclooxygenase Site. In: Honn, K.V., Marnett, L.J., Nigam, S., Dennis, E., Serhan, C. (eds) Eicosanoids and Other Bioactive Lipids in Cancer, Inflammation, and Radiation Injury, 5. Advances in Experimental Medicine and Biology, vol 507. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0193-0_11
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0193-0_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4960-0
Online ISBN: 978-1-4615-0193-0
eBook Packages: Springer Book Archive